Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3

Michael G. Johnson(Amgen (United States)), An‐Rong Li(Amgen (United States)), Jiwen Liu(Amgen (United States)), Zice Fu(Amgen (United States)), Liusheng Zhu(Amgen (United States)), Shichang Miao(Amgen (United States)), Xuemei Wang(Amgen (United States)), Qingge Xu(Amgen (United States)), Alan Huang(Amgen (United States)), Andrew P. Marcus(Amgen (United States)), Feng Xu(Amgen (United States)), Karen Ebsworth(Amgen (United States)), Emmanuel Sablan(Amgen (United States)), Jay Danao(Amgen (United States)), Jeff Kumer(Amgen (United States)), Dan Dairaghi(ChemoCentryx (United States)), Chris E. Lawrence(Amgen (United States)), Timothy J. Sullivan(Amgen (United States)), George Tonn(Amgen (United States)), Thomas J. Schall(ChemoCentryx (United States)), Tassie L. Collins, Julio C. Medina
Bioorganic & Medicinal Chemistry Letters
April 7, 2007
Cited by 105Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis